Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children <1 Year, Weeks 40, 2023, to 8, 2024, Spain
2024
· Institute of Health Carlos III (ISCIII),
· CIBER of Epidemiology and Public Health (CIBERESP),
· Government of Catalonia,
· Comunidad de Madrid,
· Junta de Andalucia,
· Junta de Castillo y Leon
This article discusses the impact of administering nirsevimab to children in Spain to prevent respiratory syncytial virus (RSV) infections requiring hospitalization. Data from the sentinel …
Ask aRCie
New Monoclonal Antibody Prevents RSV in Infants and Toddlers
This article discusses the approval of the monoclonal antibody nirsevimab-alip (Beyfortus) to prevent respiratory syncytial virus (RSV) in high-risk neonates and infants up to 24 …
Preventative Therapies for Respiratory Syncytial Virus (RSV) in Children: Where Are We Now?
This article reviews the current landscape of preventative therapies for respiratory syncytial virus (RSV) in children, focusing on the prefusion F protein as a key …
Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention
2024
This review article analyzes the Beyfortus® (Nirsevimab) Immunization Campaign's effectiveness in preventing RSV infections. Nirsevimab shows promise in reducing hospitalizations due to RSV with its …
Disarming the Respiratory Syncytial Virus
2020
· Tufts University
This editorial comments on a study about vaccinating pregnant women to protect their infants from the respiratory syncytial virus (RSV). It describes how researchers (S.A. …
Preventing Respiratory Syncytial Virus (RSV) Disease in Children
2021
· Johns Hopkins University
This brief perspective article discusses the progress and promising strategies for RSV immunization to combat the significant burden of RSV infection in young children globally. …
Challenges in Maximizing Impacts of Preventive Strategies Against Respiratory Syncytial Virus (RSV) Disease in Young Children
2022
· Yale University
This article discusses the challenges and advancements in preventive strategies against Respiratory Syncytial Virus (RSV) disease in young children. RSV is a common cause of …
Monoclonal Antibodies for Prophylaxis and Treatment of Respiratory Viral Infections
This article discusses the use of monoclonal antibodies (mAbs) to prevent and treat respiratory viral infections, especially in people with weak immune systems. It describes …
Monoclonal Antibody 75% Effective in Infants Against Respiratory Viral Infection
2022
This article describes a study on nirsevimab, a monoclonal antibody that could protect infants from RSV infections. The study involved 1,490 infants and showed that …
Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
The article discusses prevention and treatment strategies for respiratory syncytial virus (RSV), a major cause of severe lower respiratory tract disease, especially in young children. …